Advanced company searchLink opens in new window

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED

Company number 09686738

Filter by category

Filter by category


Confirmation statement filters, selecting an input will reload the page.
Confirmation statement filters, selecting an input will reload the page.

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
04 Jul 2022 SH10 Particulars of variation of rights attached to shares
23 Jun 2022 AP01 Appointment of David Min Chao as a director on 17 June 2022
15 Mar 2022 SH01 Statement of capital following an allotment of shares on 14 March 2022
  • GBP 35,469.22
10 Jan 2022 PSC05 Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 14 May 2021
07 Jan 2022 PSC05 Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 4 May 2021
07 Jan 2022 PSC05 Change of details for United Medicines Biopharma Limited as a person with significant control on 17 February 2021
05 Jan 2022 PSC05 Change of details for United Medicines Biopharma Limited as a person with significant control on 29 January 2021
30 Nov 2021 TM01 Termination of appointment of Saurabh Saha as a director on 30 November 2021
30 Nov 2021 AD01 Registered office address changed from C/O the Cambridge Partnership Ltd, the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH United Kingdom to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT on 30 November 2021
30 Nov 2021 AP04 Appointment of Oakwood Corporate Secretary Limited as a secretary on 30 November 2021
30 Nov 2021 AP01 Appointment of David John Grainger as a director on 30 November 2021
05 Nov 2021 TM02 Termination of appointment of the Cambridge Partnership Limited as a secretary on 1 November 2021
24 Oct 2021 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of alteration of Articles of Association
21 Oct 2021 MR01 Registration of charge 096867380003, created on 4 October 2021
19 Oct 2021 MR01 Registration of charge 096867380002, created on 1 October 2021
15 Oct 2021 MR01 Registration of charge 096867380001, created on 4 October 2021
30 Sep 2021 AA Total exemption full accounts made up to 31 December 2020
11 Aug 2021 CS01 Confirmation statement made on 14 July 2021 with updates
  • ANNOTATION Clarification a second filed CS01 (Statement of capital change and Shareholder information change) was registered on 08/07/22
15 Apr 2021 AA01 Previous accounting period extended from 31 July 2020 to 31 December 2020
23 Feb 2021 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
23 Feb 2021 MA Memorandum and Articles of Association
23 Feb 2021 MA Memorandum and Articles of Association
23 Feb 2021 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
12 Feb 2021 SH03 Purchase of own shares.
11 Feb 2021 PSC02 Notification of United Medicines Biopharma Limited as a person with significant control on 29 January 2021